Olympus Corporation (TYO:7733)
1,824.50
+13.00 (0.72%)
Aug 1, 2025, 3:30 PM JST
Instructure Holdings Market Cap
Olympus has a market cap or net worth of 2.05 trillion as of August 1, 2025. Its market cap has decreased by -32.94% in one year.
Market Cap
2.05T
Enterprise Value
2.03T
Revenue
997.33B
Ranking
n/a
PE Ratio
17.76
Stock Price
$1,824.50
Market Cap Chart
Since January 16, 1992, Olympus's market cap has increased from 306.98B to 2.05T, an increase of 569.05%. That is a compound annual growth rate of 5.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 2,053.84B | -23.17% |
Dec 30, 2024 | 2,673.33B | 9.70% |
Dec 29, 2023 | 2,436.97B | -18.36% |
Dec 30, 2022 | 2,985.19B | -12.37% |
Dec 30, 2021 | 3,406.39B | 17.42% |
Dec 30, 2020 | 2,900.99B | 33.60% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Chugai Pharmaceutical | 12.08T |
Daiichi Sankyo Company | 6,807.76B |
Takeda Pharmaceutical Company | 6,586.93B |
HOYA Corporation | 5,998.27B |
Otsuka Holdings | 3,938.80B |
Terumo | 3,781.04B |
Astellas Pharma | 2,822.42B |
Shionogi & | 2,166.95B |